Intensifying therapy in children with pediatric B-ALL and IKZF1 deletions leads to improved survival.
Read the related article "Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study)" on JCO.org